Licence for Botox in so-called chronic migraine.
Jes
J
Olesen
Peer
P
Tfelt-Hansen
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D015201:Meta-Analysis as Topic; D008881:Migraine Disorders / Q000517:prevention & control*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome; D006113:United Kingdom
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A